Comparative statistics by cancer site (ICD-10)

ICD-10: Comparative statistics by registry

Table 2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site


Click on country-registry for comparison

Flag Country Registry Registration periodNo. of cases included Complete FUIncomplete FU: loss to FU% with Complete FU at 5 yearsMedian FU (in months)
Alive/deadAt end of FUNo.%% lost to FU: years from diagnosis
No.%<11-33-5>5
China - Shangai1992-199562462199.530.50.00.20.10.299.756.5
Cuba1994-199580077196.3293.71.50.91.00.396.640.6
India - Barshi1993-2000333297.013.03.00.00.00.097.012.1
India - Chennai1990-199972259882.812417.26.70.80.39.492.217.4
India - Karunagappally1991-1997464597.812.20.02.20.00.097.817.6
India - Mumbai1992-19941880150179.837920.211.00.50.48.388.112.4
Thailand - Chiang Mai1993-199715311273.24126.88.58.55.93.977.112.1
Thailand - Khon Kaen1993-1997362980.6719.419.40.00.00.080.613.8
Thailand - Lampang1990-200016216098.821.20.00.01.20.098.820.6
Thailand - Songkhla1990-19991389266.74633.313.08.04.38.074.620.3
Turkey - Izmir1995-199747830864.417035.69.81.71.522.687.064.0
Zimbabwe - Harare1993-1997736994.545.55.50.00.00.094.514.1



Other tables available:

- Table 1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site
- Table 2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site
- Table 2b: Number and proportion of cases by vital status and median follow-up (in months) by site
- Table 3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site
- Table 4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group
- Table 5b: Proportion (%) of cases and 5-year absolute survival by extent of disease and site
- Table 6: Comparison of 5-year absolute and relative survival of cases diagnosed
- Table 7b: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 8: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 9: Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period